$SG

McConnell Jamie sold $93K of SG

McConnell Jamie (Chief Financial Officer) sold 15,033 shares of Sweetgreen, Inc. (SG) at $6.21 on 2026-08-17.

Original reporting
SEC EDGAR · McConnell Jamie
Published Aug 18, 2026, 9:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SG
Neutral
medium confidence
Mentioned
$SG
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SGNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details by the CFO, including share count, price, and that it was not under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone does not provide a new fundamental catalyst.

03

What to watch

The article lacks context on prior insider transactions, total holdings trend, and whether other executives sold or bought around the same period.

Relevance 3/10Novelty 3/10Timing: filed after-hours on 2026-08-18, covering a sale dated 2026-08-17

Background

This is an SEC Form 4 insider transaction disclosure for Sweetgreen, Inc. (SG).

Company-level read

Ticker impact

$SGNeutralMedium confidence
Context

Sweetgreen CFO Jamie McConnell filed a Form 4 open-market sale of 15,033 shares at $6.21 on 2026-08-17.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless follow-on selling accelerates.

Evidence & confidence

Form 4 insider sales are common and this transaction is not tied to earnings, guidance, or a corporate event in the text. The absence of a 10b5-1 plan can raise attention, but the article provides no additional context (e.g., size vs prior sales, tax/option exercise drivers).

Market effects

No clear sector read-through from a single routine insider sale.

None indicated.

None indicated.

Counterpoint

The sale may be unrelated to outlook (taxes, diversification, planned liquidity needs), so treating it as bearish could be overdone.

Key entities

  • Sweetgreen, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Jamie McConnell

    Sweetgreen CFO who sold shares via an open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SGHighAI 9/10

Sweetgreen (SG) Q2 2026 Earnings Call Transcript

Sweetgreen (SG) reported Q2 2026 revenue of $192.7M, up 4% YoY, driven by 36 net new restaurant openings. Same-store sales fell 6.2%. Restaurant-level margin was 13.1% and adjusted EBITDA was a $0.2M loss. FY2026 guidance was revised for cyclospora impacts, with comparable sales expected to decline 7% to 8% and restaurant margin 10.5% to 11.0%.

$SGHighAI 8/10

Sweetgreen Says Wraps Are a Hit With Diners, But Cyclospora Scare Clouds Outlook — BigGo Finance

Sweetgreen Inc. (NYSE:SG) said its lower-priced wraps are driving loyalty and transactions, with CEO Jonathan Neman citing about a 20% incidence rate since the national launch and a 30-day return rate above the Harvest Bowl. Cyclospora-related negative headlines in mid-July led the company to cut full-year 2026 guidance. Q2 revenue was $192.7M (+4% YoY), but comparable sales fell 6.2% and restaurant margin dropped to 13.1%.

$SGHighAI 8/10

After a Wraps Win, Sweetgreen Faces a Fresh Setback

Sweetgreen introduced lower-priced wraps after a weak Q1 to improve value perception and drive repeat visits. Wraps reached about a 20% incidence rate and improved retention, but same-store sales fell 6.2% in Q2. Revenue rose ~4% to $192.7M. A cyclospora-related demand hit led to a lowered full-year outlook and guidance.

$SGMed

Parasite Outbreak Fears Crush Restaurant Sales Weeks After RFK Jr. Said It Was “Under Control”

On July 21, HHS Secretary Robert F. Kennedy Jr. said the multistate cyclosporiasis outbreak tied to iceberg lettuce was “under control.” By Aug. 5, the CDC reported 6,358 illnesses in 15 states, 278+ hospitalizations, and two deaths. The FDA linked the recall to Taylor Farms, and restaurant chains including Sweetgreen (SG) and Salad and Go filed for Chapter 11, citing outbreak-related demand impacts.

$SGHighAI 9/10

Sweetgreen Q2 Earnings Call Highlights

Sweetgreen (NYSE:SG) reported Q2 comparable transaction declines narrowing from -11.2% in Q1 to about -3% in April-May and near flat in June. Restaurant-level profit was $25.2M (13.1% margin) and adjusted EBITDA was a $0.2M loss. Wraps drove frequency but lower check weighed mix. Sweetgreen cut 2026 outlook for disruption, expecting comps -8% to -7% and adjusted EBITDA loss of $27M to $23M.

$SGHighAI 9/10

Sweetgreen Shares Slide After Weak Second-Quarter Results and Lower Outlook

Sweetgreen (NYSE:SG) shares fell about 15% premarket after it reported Q2 2026 results that missed expectations. Revenue rose 3.8% to $192.7M, but GAAP loss widened to $0.22 per share. Comparable sales fell 6.2% and restaurant margin dropped to 13.1% from 18.9%. Sweetgreen cut full-year EBITDA guidance to about -$25M at midpoint, citing a cyclospora outbreak.